Clinicopathologic features of lung cancer patients harboring de novo EGFR T790M mutation

被引：1
|
作者：
Lee, Young Joo
Lee, Geon Kook
Lee, Yeon-Su
机构：
[1] Natl Canc Ctr, Goyang, South Korea
[2] Natl Canc Ctr, Div Convergence Technol, Goyang, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.8075
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8075
引用
收藏
页数：1
相关论文
共 50 条
  • [1] De novo EGFR T790M mutation in lung cancer patients harboring sensitive EGFR mutations
    Lee, Youngjoo
    Lee, Geon Kook
    Lee, Yeon-Su
    Zhang, Wenji
    CANCER RESEARCH, 2014, 74 (19)
  • [2] Osimertinib Depletes EGFR T790M in the Spinal Fluid of Patients with Carcinomatous Meningitis of Lung Adenocarcinoma Harboring De Novo EGFR T790M
    Senoo, Satoru
    Ohashi, Kadoaki
    Nishii, Kazuya
    Hara, Naofumi
    Kano, Hirohisa
    Ninomiya, Kiichiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (08) : E140 - E142
  • [3] Non-Small Cell Lung Cancer with De Novo EGFR T790M Mutation: Clinical Features of 22 Cases
    Heo, Mi Hwa
    Kim, Hee Kyung
    Lee, Hansang
    Cho, Jinhyun
    Park, Juyoun
    Jeong, Su-Mi
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1237 - S1238
  • [4] Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation
    Joshi, Asim
    Butle, Ashwin
    Hait, Supriya
    Mishra, Rohit
    Trivedi, Vaishakhi
    Thorat, Rahul
    Choughule, Anuradha
    Noronha, Vanita
    Prabhash, Kumar
    Dutt, Amit
    TRANSLATIONAL ONCOLOGY, 2022, 22
  • [5] Monitoring the EGFR T790M mutation in liquid biopsy in patients with lung cancer
    Cardos, G.
    Motoc, R.
    Leonte, D. G. N.
    Simion, G.
    Gurban, P.
    Iordache, F.
    Iorga, P.
    Apostol, P. P.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 436 - 437
  • [6] Effects of vandetanib on lung adenocarcinoma cells harboring an EGFR T790M mutation in vivo
    Ichihara, Eiki
    Ohashi, Kadoaki
    Takigawa, Nagio
    Osawa, Masahiro
    Takeda, Hiromasa
    Ochi, Nobuaki
    Harada, Daijiro
    Yasugi, Masayuki
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    CANCER RESEARCH, 2009, 69
  • [7] Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M
    Zhao, S.
    Jiang, T.
    Li, X.
    Zhao, C.
    Su, C.
    Ren, S.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S410 - S410
  • [8] Mixed Response of Non-Small Cell Lung Cancer Harboring the EGFR T790M Mutation to Osimertinib
    Shinno, Y.
    Goto, Y.
    Sato, J.
    Morita, R.
    Matsumoto, Y.
    Murakami, S.
    Kanda, S.
    Horinouchi, H.
    Fujiwara, Y.
    Yamamoto, N.
    Ohe, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2145 - S2145
  • [9] Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790M
    Zhao, Sha
    Li, Xuefei
    Zhao, Chao
    Jiang, Tao
    Jia, Yijun
    Shi, Jinpeng
    He, Yayi
    Li, Jiayu
    Zhou, Fei
    Gao, Guanghui
    Li, Wei
    Chen, Xiaoxia
    Su, Chunxia
    Ren, Shengxiang
    Zhou, Caicun
    LUNG CANCER, 2019, 128 : 33 - 39
  • [10] Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutation
    Lee, Sang Hoon
    Kim, Eun Young
    Kim, Arum
    Chang, Yoon Soo
    CANCER BIOLOGY & THERAPY, 2020, 21 (08) : 741 - 748
12345